STUDY Abstract: THU-113 Effectiveness of Hepatitis C Virus Screening Laws in United States: Evidence from Paid Claims Data from 2010 to 2016 – D. Mehta, et al.
Study Aims and Results: This study evaluated the effectiveness of HCV screening policies of 5 U.S. states (NY, CA, CT, MA, CO) beginning in 2014. The aim was to assess the U.S. progress in meeting the World Health Organization’s (WHO) goal of screening 90% of the world’s population for HCV infection by 2030. Researchers gathered data from a large claims database, from 2010-2016.
Compared to 2010, annual screening rates were increased by nearly 20% after 2014. In the states that passed screening laws, screening rates were increased by an additional 6%. Medicare enrollments, females, and the presence of comorbidities were associated with an increased likelihood of screening.
Projections of screening rates suggest that NY and 4 other states without screening laws were on track to reach the WHO target by 2030; 8 additional states are projected to reach the WHO target by 2040; 29 states would not attain this target by 2050.
Conclusions: Over 90% of states in the U.S. are still not on track to reach the WHO target by 2030.
Editorial Comments: As bad as this sounds, the projections may be even worse if we don’t solve the opioid crisis.
Share This Page